"BioTrinity has the charisma to motivate entrepreneurs, investors and scientists from Europe's top biotech and healthcare clusters to collect in one place. It's the gateway to European biotech."

Simon Haworth, Founder, Dynasty Biotechnology & The Sino-UK Fund

I attended BioTrinity in 2016 for the first time and it was simply amazing how many opportunities this conference provided to meet and engage people interested in ongoing activities at Eudendron. I would suggest to attend BioTrinity to those people looking for funding opportunities to advance their project or companies within the life sciences sector.

Mauro Angiolini, Managing Director, Eudendron Srl

An excellent event bringing together the best from venture capital, innovators and industry.

Aris Constantinides, Investment Director, NBGI Private Equity Limited

As always the premier biotechnology conference in Europe for investors to attend. An excellent range of companies and investors present.

Carlos Pittol, Director, Clubb Capital Ltd

BioTrinity truly deserves the accolade of Europe’s leading investment and biopartnering conference. The diversity of participants, high attendance levels of key decision makers and the ease of arranging meetings make it a crucial event on our calendar.

Lisa Evans, Life Science Insurance Advisor, Arthur J Gallagher

BioTrinity was an excellent forum in which to meet business development representatives of major companies, and at which to market our products and services.

Malcolm Young, CEO, e-Therapeutics Ltd

An essential event in our annual calendar, BioTrinity allows networking with industry leaders, informative panel discussions and a well attended exhibition.

Vicky Steadman, Director of Discovery, Selcia Ltd.

BioTrinity 2016, as Europe’s leading investment and biopartnering conference, was a great opportunity for Sanofi to increase our visibility as a partner of choice in bringing therapeutic advances and hope to patients around the world

Yvonne Naughton, Head of Business Development and New Product Planning,Sanofi

BioTrinity 2018 Highlights

Delegates 860
Companies >450
Representatives from investment firms 150
Representatives from global pharma 75
One-to-One partnering meetings scheduled >2000
Countries represented 27